NC
JANX icon

Nehal Chopra’s Janux Therapeutics JANX Stock Holding History

Nehal Chopra’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-13,288
Closed -$1.14M – 33
2025
Q2 		$1.14M Sell
13,288
-63,512
-83% -$1.67M 0.52% 23
2025
Q1 		$2.07M Sell
76,800
-102,507
-57% -$3.86M 0.67% 21
2024
Q4 		$9.6M Buy
179,307
+150,507
+523% +$7.96M 1.47% 17
2024
Q3 		$1.31M Sell
28,800
-76,957
-73% -$3.35M 0.35% 28
2024
Q2 		$4.43M Buy
105,757
+85,757
+429% +$4.03M 1.34% 20
2024
Q1 		$753K Buy
+20,000
New +$436K 0.4% 32

Other funds holding JANX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Nehal Chopra's JANX Position: Q3 2025 in Review

Nehal Chopra sold out of Janux Therapeutics (JANX) in Q3 2025, closing a stake of 13,288 shares — an estimated $1.14M sold.

Nehal Chopra first reported a position in JANX in Q1 2024 and held it in 6 quarters. The position peaked at $9.6M in Q4 2024. 174 funds tracked by Wall St. Rank hold JANX as of Q3 2025.

  • Nehal Chopra reported no remaining Janux Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Nehal Chopra sold 13,288 Janux Therapeutics shares in Q3 2025, an estimated $1.14M.
  • Nehal Chopra first reported a position in Janux Therapeutics in Q1 2024 and held it in 6 quarters.
  • Nehal Chopra's Janux Therapeutics position peaked at $9.6M in Q4 2024.
  • 174 funds tracked by Wall St. Rank held Janux Therapeutics as of Q3 2025.

Based on Ratan Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.